As the year draws to a close, it's as good a time as any to review one's investments and consider adding more money into the stock market. The goal shouldn't be to take advantage of the January effect -- the tendency equities have to rise early in the year. These market trends are short-lived, so as usual, it's better to focus on those companies that can perform well in the long run.

Two great examples in the healthcare sector are Abbott Laboratories (NYSE: ABT) and Intuitive Surgical (NASDAQ: ISRG). Let's investigate why you can safely put your hard-earned money into both stocks this month.

Shares of medical device specialist Abbott Laboratories have failed to keep pace with the market this year. There are several reasons, one of which is that its coronavirus diagnostic revenue continues to fluctuate. Abbott's total sales haven't been consistently pointing up as a result. In the third quarter, the healthcare giant's revenue of $10.1 billion decreased by 2.6% year over year.

Continue reading

Source Fool.com